Results
339
Companies with a Future performance score of at least 3, ordered by Future performance score.
339 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INIT New | SEK 7.00 | -2.1% | -22.0% | SEK 392.9m | SEK 22.50 | PB16.2x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
WAYS | SEK 15.62 | -4.3% | -45.2% | SEK 126.0m | SEK 36.50 | PS1x | E113.3% | 0% | Tech | ||
ACE | SEK 3.16 | 8.2% | -49.4% | SEK 303.2m | SEK 8.25 | PB2.8x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | SEK 3.54 | 4.1% | -23.9% | SEK 85.9m | SEK 8.00 | PS2.3x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
DIGN | SEK 1.25 | 0% | -40.2% | SEK 100.7m | SEK 5.50 | PS1.2x | E118.7% | n/a | Healthcare | ||
TFBANK | SEK 406.00 | 6.3% | 148.5% | SEK 8.7b | SEK 456.67 | PB3.5x | E22.3% | n/a | Banks | ||
YUBICO | SEK 242.50 | 12.3% | 76.0% | SEK 20.9b | SEK 322.50 | PE60.4x | E29.9% | n/a | Software | ||
CAMX | SEK 568.00 | -2.9% | 15.5% | SEK 33.4b | SEK 745.00 | PE125.5x | E83.2% | n/a | Pharmaceuticals & Biotech | ||
ENRAD | SEK 11.20 | -11.1% | 126.7% | SEK 273.4m | SEK 8.90 | PE69.6x | E50.9% | n/a | Capital Goods | ||
ENGCON B | SEK 102.00 | 8.4% | 27.0% | SEK 15.5b | SEK 108.33 | PE89.4x | E42.1% | 0.9% | Capital Goods | ||
JOBS | SEK 20.40 | 4.6% | -22.1% | SEK 101.4m | SEK 39.00 | PE12.4x | E44.5% | 8.1% | Commercial Services | ||
SKOLON | SEK 29.30 | -1.7% | 22.6% | SEK 777.7m | SEK 37.50 | PS5.3x | E135.5% | 1.9% | Software | ||
TRUE B | SEK 55.25 | 6.8% | 94.5% | SEK 19.0b | SEK 64.14 | PE38.7x | E25.8% | 0.7% | Software | ||
SPAGO | SEK 0.21 | 4.0% | -43.4% | SEK 73.1m | SEK 0.80 | PS10.5x | E119.8% | n/a | Pharmaceuticals & Biotech | ||
BONEX | SEK 374.80 | 0% | 85.7% | SEK 24.7b | SEK 422.33 | PE272.3x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
XBRANE | SEK 0.17 | 5.7% | -91.8% | SEK 253.9m | SEK 0.45 | PS1.3x | E128.5% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 268.00 | -0.4% | 9.4% | SEK 3.4b | n/a | PE37.8x | E33.3% | 2.0% | Capital Goods | ||
MIPS | SEK 484.80 | 4.0% | 46.8% | SEK 12.8b | SEK 613.00 | PE123.5x | E49.6% | 1.2% | Consumer Durables | ||
MILDEF | SEK 123.80 | -3.1% | 69.1% | SEK 5.6b | SEK 135.50 | PE103.1x | E84.9% | 0.4% | Capital Goods | ||
EQL | SEK 76.40 | 0% | 121.4% | SEK 2.2b | SEK 65.00 | PE71.2x | E53.3% | n/a | Healthcare | ||
EGTX | SEK 5.92 | 0.3% | -3.0% | SEK 2.1b | SEK 11.50 | PS31.3x | E97.3% | n/a | Pharmaceuticals & Biotech | ||
BIOA B | SEK 195.60 | -0.2% | -16.7% | SEK 17.3b | SEK 322.00 | PS103.4x | E51.3% | 0% | Pharmaceuticals & Biotech | ||
PAX | SEK 72.00 | 0.3% | 92.0% | SEK 1.4b | SEK 80.00 | PE52.1x | E60.8% | n/a | Healthcare | ||
SECT B | SEK 247.45 | -1.4% | 33.3% | SEK 47.7b | SEK 285.00 | PE124x | E27.9% | 0.4% | Healthcare |